Cargando…
Assessment of Physicochemical Properties of Rituximab Related to Its Immunomodulatory Activity
Rituximab is a chimeric monoclonal antibody employed for the treatment of CD20-positive B-cell non-Hodgkin's lymphoma, chronic lymphocytic leukemia, rheumatoid arthritis, granulomatosis with polyangiitis and microscopic polyangiitis. It binds specifically to the CD20 antigen expressed on pre-B...
Autores principales: | Miranda-Hernández, Mariana P., López-Morales, Carlos A., Ramírez-Ibáñez, Nancy D., Piña-Lara, Nelly, Pérez, Nestor O., Molina-Pérez, Aarón, Revilla-Beltri, Jorge, Flores-Ortiz, Luis F., Medina-Rivero, Emilio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4418000/ https://www.ncbi.nlm.nih.gov/pubmed/25973441 http://dx.doi.org/10.1155/2015/910763 |
Ejemplares similares
-
New Alternatives for Autoimmune Disease Treatments: Physicochemical and Clinical Comparability of Biosimilar Etanercept
por: Miranda-Hernández, Mariana P., et al.
Publicado: (2016) -
Pharmacokinetic Comparability of a Biosimilar Trastuzumab Anticipated from Its Physicochemical and Biological Characterization
por: Miranda-Hernández, Mariana P., et al.
Publicado: (2015) -
Response to: Comment on “New Alternatives for Autoimmune Disease Treatments: Physicochemical and Clinical Comparability of Biosimilar Etanercept”
por: Miranda-Hernández, Mariana P., et al.
Publicado: (2018) -
Physicochemical and Biological Characterization of a Biosimilar Trastuzumab
por: López-Morales, Carlos A., et al.
Publicado: (2015) -
Validation of three viable-cell counting methods: Manual, semi-automated, and automated
por: Cadena-Herrera, Daniela, et al.
Publicado: (2015)